Skip to content

Jill Ge

Counsel

Shanghai

JG

Jill Ge

Counsel

Shanghai

Jill covers the full spectrum of IP litigation and transactions in China. Jill has extensive experience in contentious patent, trade secret and trade mark matters involving multinationals and in resolving cross-border disputes. 

Drawing on her litigation experience, Jill also routinely advises on IP and data heavy transactions and counsels technology and life science clients in relation to their development of IP strategies, as well as IP related regulatory and competition law issues. Jill has written extensively on IP developments in China and one of her articles was quoted in an English Court of Appeal judgment. Jill has a technical background in physics and materials engineering. She studied law and was trained in the US and also qualified in China.  

News & insights

How EasyMile is tackling the under-30mph market and the impact of the pandemic on the autonomous vehicle industry

Publications: 29 JULY 2021

Propel: Standard Essential Patents and the self-driving industry

SEPs and FRAND – two legal issues that have resulted in global patent disputes in the mobile device space is now beginning to make its presence known in the automotive industry.

Read more
Skyline

Publications: 27 MAY 2021

Hitachi Metals: Essential Patents Recognised as Essential Facility in China

On 23 April 2021, the Ningbo Intermediate Court handed down the long-awaited decision in Ningbo Ketian Magnet Co., Ltd. v. Hitachi Metals, Ltd. 

Read more
Person wearing protective clothing and holding apparatus in science lab

Blog Post: 05 NOVEMBER 2020

China: Patent Law Amendment brings sea change to pharmaceutical patent regime

On 17 October 2020, the top legislature in China passed the Fourth Amendment to the PRC Patent Law (“Amendment”) which will take effect on 1 June 2021. The Amendment is significant as it introduces…

Read more
Chemicals getting tested at a pharmaceutical factory

Publications: 04 NOVEMBER 2020

China: Patent Law Amendment brings sea change to pharmaceutical patent regime

On 17 October 2020, the top legislature in China passed the Fourth Amendment to the PRC Patent Law (“Amendment”) which will take effect on 1 June 2021. The Amendment is significant as it introduces…

Read more

JG

Office

Shanghai

Allen & Overy LLP Shanghai Representative Office (UK)
15F, Phase II, Shanghai IFC, 8 Century Avenue, Pudong
Shanghai
200120

View office →

Qualifications

Professional

Admitted to New York Bar, 2012

Qualified in China (non-practicing), 2020

Academic

J.D., cum laude, University of Minnesota Law School

M.S., Materials Science and Engineering, University of California, Irvine

B.S., Physics, Fudan University 

Published Work

  • Co-author, “China: Patent Law Amendment brings sea change to pharmaceutical patent regime”, A&O alert, November 2020
  • Author, “How a Chinese court would have decided the Unwired Planet appeal”, IAM Blog, November 2018
  • Author, “China: Does bifurcation mean patent validity has to be decided first?”, Comparative Patent Remedies, May 2018
  • Co-author, “The Patent Litigation Law Review, China Chapter – Edition 1”, The Law Reviews, January 2018
  • Author, “Damages trends in China: what the shifting landscape means for rights holders”, World Trademark Review Magazine, October 2017
  • Author, “China: Beijing IP Court publishes initial results of case precedent pilot project”, INTA Bulletin, September 2017
  • Co-author, “Iwncomm v Sony: first SEP-based injunction granted in China”, A&O alert, April 2017
  • Author, “The Beijing IP Court’s 50 million RMB judgment in WatchData v Hengbao”, Comparative Patent Remedies, January 2017
  • Co-author, “SEP-based injunction, down but not out”, Kluwer Patent Blog, April 2016